Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL)

J. A. Radford; F. Morschhauser; A. Van Hoof; U. Vitolo; P. Soubeyran; H. Tilly; P. C. Huijgens; A. Kolstad; M. Kunz; A. Hagenbeek

Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL)

J. A. Radford, F. Morschhauser, A. Van Hoof, U. Vitolo, P. Soubeyran, H. Tilly, P. C. Huijgens, A. Kolstad, M. Kunz, A. Hagenbeek

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	0433
Pages (from-to)	174
Number of pages	1
Journal	Haematologica
Volume	93
Issue number	Supplement 1
Publication status	Published - Jun 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://haematologica.org/issue/view/178

Cite this

Radford, J. A., Morschhauser, F., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A., Kunz, M., & Hagenbeek, A. (2008). Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL). Haematologica, 93(Supplement 1), 174. Article 0433. https://haematologica.org/issue/view/178

@article{488fb4b408384e31bf057efbb2ec5567,

title = "Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL)",

author = "Radford, {J. A.} and F. Morschhauser and {Van Hoof}, A. and U. Vitolo and P. Soubeyran and H. Tilly and Huijgens, {P. C.} and A. Kolstad and M. Kunz and A. Hagenbeek",

year = "2008",

month = jun,

language = "English",

volume = "93",

pages = "174",

journal = "Haematologica",

issn = "1592-8721",

publisher = "Ferrata Storti Foundation",

number = "Supplement 1",

}

Radford, JA, Morschhauser, F, Van Hoof, A, Vitolo, U, Soubeyran, P, Tilly, H, Huijgens, PC, Kolstad, A, Kunz, M & Hagenbeek, A 2008, 'Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL)', Haematologica, vol. 93, no. Supplement 1, 0433, pp. 174. <https://haematologica.org/issue/view/178>

Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL). / Radford, J. A.; Morschhauser, F.; Van Hoof, A. et al.
In: Haematologica, Vol. 93, No. Supplement 1, 0433, 06.2008, p. 174.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL)

AU - Radford, J. A.

AU - Morschhauser, F.

AU - Van Hoof, A.

AU - Vitolo, U.

AU - Soubeyran, P.

AU - Tilly, H.

AU - Huijgens, P. C.

AU - Kolstad, A.

AU - Kunz, M.

AU - Hagenbeek, A.

PY - 2008/6

Y1 - 2008/6

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000263430200434&KeyUID=WOS:000263430200434

M3 - Meeting Abstract

SN - 1592-8721

VL - 93

SP - 174

JO - Haematologica

JF - Haematologica

IS - Supplement 1

M1 - 0433

ER -

Results from the randomized phase 3 first-line indolent trial (FIT) of consolidation of first remission with 90Y-ibritumomab tiuxetan in advanced follicular non-Hodgkin's lymphoma (FL)

UN SDGs

Access to Document

Other files and links

Cite this